Literature DB >> 9811675

Mouse mammary tumor virus sequences responsible for activating cellular oncogenes.

S L Grimm1, S K Nordeen.   

Abstract

Integration of mouse mammary tumor virus (MMTV) near the int genes results in the inappropriate expression of these proto-oncogenes and initiates events that lead to the formation of mammary adenocarcinomas. In most cases, the MMTV provirus integrates in a transcriptional orientation opposite that of the int genes. We have used a novel, vector-based system designed to recapitulate the integration of MMTV upstream of the int-2 promoter. Compared to a cellular promoter or another retroviral promoter, the MMTV long terminal repeat (LTR) in this configuration is particularly efficacious at activating the int-2 promoter. The sequences responsible for enhancing the activity of the int-2 promoter map to two domains in the 5' end of the MMTV LTR. One domain is a previously defined element; the second is an element delineated by these studies that acts synergistically with the first. Both of these elements display mammary cell-specific activity. Thus, even though the MMTV promoter itself is weak without hormonal stimulation, viral integration can position the 5' LTR elements to efficiently activate transcription from cellular proto-oncogenes. Other functional elements in the LTR have little effect on the activation of the int-2 promoter. Even stimulation of the MMTV promoter with steroid hormones only modestly activates transcription from the int-2 promoter, suggesting that the 5' elements of the LTR are the predominant determinants of the tissue- and orientation-specific activation of cellular promoters by MMTV.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9811675      PMCID: PMC110428     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  The matrix attachment region-binding protein SATB1 participates in negative regulation of tissue-specific gene expression.

Authors:  J Liu; D Bramblett; Q Zhu; M Lozano; R Kobayashi; S R Ross; J P Dudley
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Characterization of an NF-1/CTF family member as a functional activator of the mouse mammary tumor virus long terminal repeat 5' enhancer.

Authors:  P Kusk; S John; G Fragoso; J Michelotti; G L Hager
Journal:  J Biol Chem       Date:  1996-12-06       Impact factor: 5.157

4.  Epithelial mouse mammary cell line exhibiting normal morphogenesis in vivo and functional differentiation in vitro.

Authors:  K G Danielson; C J Oborn; E M Durban; J S Butel; D Medina
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

5.  The 5' enhancer of the mouse mammary tumor virus long terminal repeat contains a functional AP-2 element.

Authors:  J Mellentin-Michelotti; S John; W D Pennie; T Williams; G L Hager
Journal:  J Biol Chem       Date:  1994-12-16       Impact factor: 5.157

6.  Sequence-specific DNA binding by Ku autoantigen and its effects on transcription.

Authors:  W Giffin; H Torrance; D J Rodda; G G Préfontaine; L Pope; R J Hache
Journal:  Nature       Date:  1996-03-21       Impact factor: 49.962

7.  Tumorigenesis by mouse mammary tumor virus: evidence for a common region for provirus integration in mammary tumors.

Authors:  G Peters; S Brookes; R Smith; C Dickson
Journal:  Cell       Date:  1983-06       Impact factor: 41.582

8.  Expression and regulation of Escherichia coli lacZ gene fusions in mammalian cells.

Authors:  C V Hall; P E Jacob; G M Ringold; F Lee
Journal:  J Mol Appl Genet       Date:  1983

Review 9.  MMTV-induced mutations in mouse mammary tumors: their potential relevance to human breast cancer.

Authors:  R Callahan
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 10.  Oncogene activation and oncogene cooperation in MMTV-induced mouse mammary cancer.

Authors:  F van Leeuwen; R Nusse
Journal:  Semin Cancer Biol       Date:  1995-06       Impact factor: 15.707

View more
  6 in total

1.  Sequence and genetic analyses of the 3' terminus and integration sites of the RIII/Sa mouse mammary tumor (MMTV) exogenous provirus.

Authors:  P Popken-Harris; L Pliml; L Harris
Journal:  Virus Genes       Date:  2001       Impact factor: 2.332

2.  A cis-Acting Element Downstream of the Mouse Mammary Tumor Virus Major Splice Donor Critical for RNA Elongation and Stability.

Authors:  Shaima Akhlaq; Neena G Panicker; Pretty S Philip; Lizna M Ali; Jaquelin P Dudley; Tahir A Rizvi; Farah Mustafa
Journal:  J Mol Biol       Date:  2018-09-01       Impact factor: 5.469

3.  ICM Web: the interactive chromatin modeling web server.

Authors:  Richard C Stolz; Thomas C Bishop
Journal:  Nucleic Acids Res       Date:  2010-06-11       Impact factor: 16.971

4.  Transgenic mouse models of breast cancer.

Authors:  Angelina T Regua; Austin Arrigo; Daniel Doheny; Grace L Wong; Hui-Wen Lo
Journal:  Cancer Lett       Date:  2021-06-06       Impact factor: 9.756

Review 5.  Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays.

Authors:  Thilo M Buck; Jan Wijnholds
Journal:  Int J Mol Sci       Date:  2020-06-12       Impact factor: 5.923

6.  A 5' distal palindrome within the mouse mammary tumor virus-long terminal repeat recruits a mammary gland-specific complex and is required for a synergistic response to progesterone plus prolactin.

Authors:  Joseph E Morabito; Josephine F Trott; Dorian M Korz; Heather E Fairfield; Sarah H Buck; Russell C Hovey
Journal:  J Mol Endocrinol       Date:  2008-06-04       Impact factor: 5.098

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.